Health care startups that raised Series D or later in Asia
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Barty Medical | Hangzhou | Series D | $29.5M | 2026-09-23 |
| Kai Medtech | Minhang | Series D | $73.9M | 2026-07-28 |
| Vivolight | Nanshanqu | Series E | $13.9M | 2026-06-01 |
| Full-Life Technologies | Shanghai | Series D | $109.0M | 2026-05-18 |
| Aidoc | Tel Aviv | Series E | $150.0M | 2026-04-29 |
| New Radiomedicine Technology | Chengdu | Series E | $145.4M | 2026-04-03 |
| Cult.fit | Bangalore | Series G | $46.8M | 2026-03-21 |
| CORXEL Pharmaceuticals | Shanghai | Series D | $287.0M | 2026-01-22 |
8 rows of the CSV in 5 of its 18 columns.
- The 223 health care startups in Asia whose last round is Series D or later have raised $21.1B in total.
- 26 of them closed their most recent round in the last 12 months, $1.6B combined.
- The largest of those rounds is CORXEL Pharmaceuticals' $287.0M Series D, dated January 2026.
- The most recent is Haoxinqing's $44.7M Series D on 30 September 2026.
- Qiming Venture Partners is an investor in 6 of them, more than any other fund.
- Biotech is the most common other sector, with 86 companies (39%).
- 1% were founded in 2020 or later; the median founding year is 2013.
- The most common team size is 51 to 100 employees (24% of companies with a recorded size).
- 3 are unicorns, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
30 of 223| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Barty Medical | Barty Medical provides hospital healthcare services to patients. | Health care | Hangzhou, China | Series D | $29.5M | 2026-09-23 | $46.7M | Shenzhen Guozhong Venture Capital Management, Sinowisdom, Sunz Fund | 101 to 250 | 2015 |
| Kai Medtech | Kai Medtech markets and sells vascular intervention medical devices. | Health care | Minhang, China | Series D | $73.9M | 2026-07-28 | $105.3M | Shenzhen Capital Group, Wuxi Capital, Hengxu Capital +1 | 51 to 100 | 2019 |
| Vivolight | Vivolight conducts medical research and develops intravascular interventional imaging technology. | Biotech | Nanshanqu, China | Series E | $13.9M | 2026-06-01 | $52.2M | CAS Star, TusStar | 51 to 100 | 2012 |
| Full-Life Technologies | Full-Life Technologies develops, produces, and commercializes medicines for cancer therapy. | Biotech | Shanghai, China | Series D | $109.0M | 2026-05-18 | $337.3M | Sky9 Capital, Chengwei Capital, Prosperity7 Ventures +1 | 51 to 100 | 2021 |
| Aidoc | Aidoc develops artificial intelligence software for healthcare imaging and clinical workflows. | Artificial intelligence | Tel Aviv, Israel | Series E | $150.0M | 2026-04-29 | $564.0M | General Catalyst, TCV, TLV Partners +2 | 251 to 500 | 2016 |
| New Radiomedicine Technology | New Radiomedicine Technology supplies medical isotopes in China. | Biotech | Chengdu, China | Series E | $145.4M | 2026-04-03 | $330.6M | Chengdu Science and Technology Venture Capital | 101 to 250 | 2016 |
| Cult.fit Unicorn | Cult.fit offers digital and offline health services covering fitness, nutrition, and mental well-being. | Health care | Bangalore, India | Series G | $46.8M | 2026-03-21 | $683.6M | Accel, InnoVen Capital | 501 to 1,000 | 2016 |
| CORXEL Pharmaceuticals | CORXEL Pharmaceuticals develops medicines for underserved patients. | Biotech | Shanghai, China | Series D | $287.0M | 2026-01-22 | $451.8M | Leaps by Bayer, RTW Investments | 51 to 100 | 2019 |
| Surgerii Technology | Surgerii Technology develops minimally invasive surgical robots. | Hardware | Haidian, China | Series D | $100.0M | 2025-12-31 | $100.0M | Shunwei Capital, SDIC Venture Capital, Shanghai Biomedical Industrial Equity Investment Fund +1 | 11 to 50 | 2014 |
| MAXVAX | MAXVAX develops and commercializes novel vaccines. | Biotech | Shuangliu, China | Series D | $27.4M | 2025-12-25 | $284.2M | IDG Capital, Shenzhen Capital Group, Korea Investment Partners +1 | 251 to 500 | 2016 |
| The Sleep Company | The Sleep Company develops a mattress that adapts to its user's body shape. | Health care | Mumbai, India | Series D | $54.7M | 2025-08-06 | $81.7M | Alteria Capital, Fireside Ventures, Premji Invest +1 | 1,001 to 5,000 | 2019 |
| METiS Pharmaceuticals | METiS Pharmaceuticals is an AI-driven drug formulation company. | Artificial intelligence | Hangzhou, China | Series D | $55.7M | 2025-08-04 | $391.7M | Source Code Capital, Frees Fund, Luminous Ventures (former Lightspeed China Partners) | 51 to 100 | 2020 |
| Weimai | Weimai uses big data and artificial intelligence to digitize its healthcare service platform. | Artificial intelligence | Yuhang, China | Series D | $27.3M | 2025-01-07 | $257.3M | IDG Capital, Matrix Partners China, Source Code Capital +1 | 101 to 250 | 2013 |
| IMPACT Therapeutics | IMPACT Therapeutics develops similar drugs to treat cancer. | Biotech | Nanjing, China | Series D | $34.6M | 2024-11-15 | BioVenture, Lilly Asia Ventures, Decheng Capital +2 | 51 to 100 | 2009 | |
| DK MedTech | DK MedTech manufactures vascular interventional medical device products. | Health care | Suzhou, China | Series E | $24.5M | 2024-06-21 | $36.2M | Qiming Venture Partners, Legend Capital, Oriza Seed Capital (Oriza Yuandian) +1 | 251 to 500 | 2015 |
| Yidao Biotechnology | Yidao Biotechnology researches and develops vaccines and biomedical products. | Biotech | Suzhou, China | Series D | $25.2M | 2024-05-09 | Qiming Venture Partners, Northern Light Venture Capital | 2017 | ||
| Alodokter | Alodokter is a digital health platform offering telemedicine and doctor consultations to patients. | Health care | Jakarta, Indonesia | Series D | $5.2M | 2024-02-21 | $53.3M | 500 Global, Samsung Ventures, Golden Gate Ventures +2 | 251 to 500 | 2014 |
| Rehab | Rehab provides information and communication technology and digital services for the medical care field. | Health care | Tokyo, Japan | Series D | $6.7M | 2024-02-16 | $24.4M | Global Brain Corporation, Mitsubishi UFJ Capital, SMBC Venture Capital +2 | 101 to 250 | 2016 |
| Clove Dental | Clove Dental is a dental chain providing end-to-end oral healthcare services. | Health care | New Delhi, India | Series E | $50.1M | 2023-11-24 | $117.0M | Investcorp, SPDG, Qatar Investment Authority +1 | 1,001 to 5,000 | 2011 |
| Atom Bioscience & Pharmaceutical | Atom Bioscience is a clinical-stage biotechnology company. | Biotech | Suzhou, China | Series D | $82.1M | 2023-10-16 | Fortune Venture Capital, Oriza Holdings, Kaitai Capital +1 | 11 to 50 | 2012 | |
| Halodoc | Halodoc is a health-tech platform that connects patients with doctors, insurers, labs, and pharmacies. | Fintech | Jakarta, Indonesia | Series D | $100.0M | 2023-07-28 | $245.0M | Korea Investment Partners, Bill & Melinda Gates Foundation, Gojek | 501 to 1,000 | 2016 |
| Landing Medical High Technology | Landing Medical High Technology develops AI-driven diagnostic technology for cervical cancer screening. | Artificial intelligence | Wuhan, China | Series D | $50.1M | 2021-11-10 | $50.1M | China Merchants Venture Capital, Dalton Venture, Sangel Capital | 251 to 500 | 2000 |
| Shukun Technology | Shukun Technology develops AI diagnostic systems for chronic diseases in China. | Artificial intelligence | Beijing, China | Series D | $105.8M | 2021-08-17 | $296.4M | Qiming Venture Partners, Goldman Sachs, 5Y Capital +1 | 501 to 1,000 | 2017 |
| Infervision | Infervision uses deep learning and computer vision to help diagnose cancers. | Artificial intelligence | Beijing, China | Series D | $140.0M | 2021-07-23 | $214.7M | Sequoia Capital, Qiming Venture Partners, CDH Investments +1 | 51 to 100 | 2015 |
| Atonarp | Atonarp analyzes chemical composition by combining molecular science with data processing algorithms. | Energy | Tokyo, Japan | Series D | $50.0M | 2021-05-18 | $101.5M | SMBC Venture Capital, SBI Investment, Venture Labo Investment +1 | 51 to 100 | 2009 |
| Supermonkey | Supermonkey develops and operates a mobile app that provides fitness services. | Health care | Shenzhen, China | Series E | $15.5M | 2021-05-06 | CICC, PreAngel, Fosun RZ Capital +1 | 51 to 100 | 2014 | |
| Keep Unicorn | Keep is a mobile fitness community offering training programs for different groups of people. | Education | Beijing, China | Series F | $360.0M | 2021-01-10 | Goldman Sachs, Hillhouse Investment, Coatue +1 | 501 to 1,000 | 2014 | |
| DXY Unicorn | DXY is an online healthcare community connecting doctors, consumers, and healthcare organizations. | Biotech | Hangzhou, China | Series E | $500.0M | 2020-12-29 | $682.0M | Shunwei Capital, DCM Ventures, Legend Capital +1 | 101 to 250 | 2000 |
| Practo | Practo is an mhealth platform that connects patients with healthcare providers for appointments and consultations. | Health care | Bangalore, India | Series D | $32.0M | 2020-08-15 | $228.2M | Sequoia Capital, Peak XV Partners, Thrive Capital +1 | 501 to 1,000 | 2008 |
| XACT Robotics | XACT Robotics develops a platform technology for robotic needle steering in minimally invasive interventional procedures. | Hardware | Caesarea, Israel | Series D | $36.0M | 2019-11-13 | Chasing Value Asset Management | 51 to 100 | 2013 |
Table 1. Health care startups that raised Series D or later in Asia: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 223.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CORXEL Pharmaceuticals | CORXEL Pharmaceuticals develops medicines for underserved patients. | Biotech | Shanghai, China | Series D | $287.0M | 2026-01-22 | $451.8M | Leaps by Bayer, RTW Investments | 51 to 100 | 2019 |
| 2 | Aidoc | Aidoc develops artificial intelligence software for healthcare imaging and clinical workflows. | Artificial intelligence | Tel Aviv, Israel | Series E | $150.0M | 2026-04-29 | $564.0M | General Catalyst, TCV, TLV Partners +2 | 251 to 500 | 2016 |
| 3 | New Radiomedicine Technology | New Radiomedicine Technology supplies medical isotopes in China. | Biotech | Chengdu, China | Series E | $145.4M | 2026-04-03 | $330.6M | Chengdu Science and Technology Venture Capital | 101 to 250 | 2016 |
| 4 | Full-Life Technologies | Full-Life Technologies develops, produces, and commercializes medicines for cancer therapy. | Biotech | Shanghai, China | Series D | $109.0M | 2026-05-18 | $337.3M | Sky9 Capital, Chengwei Capital, Prosperity7 Ventures +1 | 51 to 100 | 2021 |
| 5 | Surgerii Technology | Surgerii Technology develops minimally invasive surgical robots. | Hardware | Haidian, China | Series D | $100.0M | 2025-12-31 | $100.0M | Shunwei Capital, SDIC Venture Capital, Shanghai Biomedical Industrial Equity Investment Fund +1 | 11 to 50 | 2014 |
| 6 | Kai Medtech | Kai Medtech markets and sells vascular intervention medical devices. | Health care | Minhang, China | Series D | $73.9M | 2026-07-28 | $105.3M | Shenzhen Capital Group, Wuxi Capital, Hengxu Capital +1 | 51 to 100 | 2019 |
| 7 | Cult.fit Unicorn | Cult.fit offers digital and offline health services covering fitness, nutrition, and mental well-being. | Health care | Bangalore, India | Series G | $46.8M | 2026-03-21 | $683.6M | Accel, InnoVen Capital | 501 to 1,000 | 2016 |
| 8 | Barty Medical | Barty Medical provides hospital healthcare services to patients. | Health care | Hangzhou, China | Series D | $29.5M | 2026-09-23 | $46.7M | Shenzhen Guozhong Venture Capital Management, Sinowisdom, Sunz Fund | 101 to 250 | 2015 |
| 9 | MAXVAX | MAXVAX develops and commercializes novel vaccines. | Biotech | Shuangliu, China | Series D | $27.4M | 2025-12-25 | $284.2M | IDG Capital, Shenzhen Capital Group, Korea Investment Partners +1 | 251 to 500 | 2016 |
| 10 | Vivolight | Vivolight conducts medical research and develops intravascular interventional imaging technology. | Biotech | Nanshanqu, China | Series E | $13.9M | 2026-06-01 | $52.2M | CAS Star, TusStar | 51 to 100 | 2012 |
Table 2. Health care startups that raised Series D or later in Asia: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Qiming Venture Partners | Venture capital firm | Shanghai, China | 6 | 3% | ||
| 2 | Matrix Partners China | Venture capital firm | Beijing, China | 4 | 2% | ||
| 3 | Shenzhen Capital Group | Venture capital firm | Nanshan, China | 3 | 1% | 2 | Kai Medtech, MAXVAX |
| 4 | IDG Capital | Private equity firm | Beijing, China | 3 | 1% | 1 | MAXVAX |
| 5 | CICC | Investment bank | Beijing, China | 3 | 1% | ||
| 6 | Source Code Capital | Venture capital firm | Chaoyang, China | 3 | 1% | ||
| 7 | OurCrowd | Venture capital firm | Jerusalem, Israel | 3 | 1% | ||
| 8 | BioVenture | Venture capital firm | Suzhou, China | 3 | 1% | ||
| 9 | Eight Roads Ventures | Venture capital firm | London, United Kingdom | 3 | 1% | ||
| 10 | SMBC Venture Capital | Corporate venture arm | Tokyo, Japan | 3 | 1% | ||
| 11 | Global Brain Corporation | Venture capital firm | Tokyo, Japan | 3 | 1% | ||
| 12 | CDH Investments | Private equity firm | Kowloon City, Hong Kong | 3 | 1% | ||
| 13 | Northern Light Venture Capital | Venture capital firm | Beijing, China | 3 | 1% | ||
| 14 | 5Y Capital | Venture capital firm | Xuhui, China | 3 | 1% | ||
| 15 | Sinowisdom | Venture capital firm | Hangzhou, China | 2 | 1% | 1 | Barty Medical |
Table 3. Health care startups that raised Series D or later in Asia: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
Table 4. Health care startups that raised Series D or later in Asia by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series D+ | 223 | 100% | $38.7M |
Table 5. Health care startups that raised Series D or later in Asia by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Countries
| Countries | Companies | Share |
|---|---|---|
| China | 166 | 74% |
| Israel | 18 | 8% |
| Japan | 16 | 7% |
| India | 9 | 4% |
| South Korea | 8 | 4% |
| Taiwan | 3 | 1% |
| Indonesia | 2 | 1% |
| Hong Kong | 1 | 0% |
Table 6. Health care startups that raised Series D or later in Asia by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 7. Health care startups that raised Series D or later in Asia by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| September 2026 | 5 | 19% | $283.0M |
| July 2026 | 2 | 8% | $110.8M |
| June 2026 | 2 | 8% | $60.8M |
| May 2026 | 2 | 8% | $116.9M |
| April 2026 | 4 | 15% | $424.6M |
| March 2026 | 4 | 15% | $92.8M |
| January 2026 | 2 | 8% | $294.7M |
| December 2025 | 5 | 19% | $194.8M |
Table 8. Health care startups that raised Series D or later in Asia: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 21 | 9% | $1.4B |
| 2025 | 27 | 12% | $886.2M |
| 2024 | 23 | 10% | $221.4M |
| 2023 | 18 | 8% | $670.2M |
| 2022 | 21 | 9% | $1.1B |
| 2021 | 36 | 16% | $3.7B |
Table 9. Health care startups that raised Series D or later in Asia by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2020 to 2022 | 3 | 1% |
| 2015 to 2019 | 70 | 31% |
| 2010 to 2014 | 85 | 38% |
| Before 2010 | 65 | 29% |
Table 10. Health care startups that raised Series D or later in Asia by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 7 | 3% |
| 11 to 50 | 49 | 22% |
| 51 to 100 | 52 | 24% |
| 101 to 250 | 39 | 18% |
| 251 to 500 | 25 | 11% |
| 501 to 1,000 | 26 | 12% |
| 1,001 to 5,000 | 17 | 8% |
| 5,001 to 10,000 | 2 | 1% |
| 10,001 or more | 1 | 0% |
Table 11. Health care startups that raised Series D or later in Asia by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its most recent funding round is Series D or later and its headquarters is in Asia. On 16 November 2026 that is 223 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 30 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 223 rows: 45 have no round amount, 0 no city and 48 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in Asia whose last round is Series D or later are on the list?
- 223, in the file dated 16 November 2026. 26 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 223 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.